SEC Form 4 · accession 0001179110-15-005347
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Walter Peltz
Officer — Chief Executive Officer · Director
Period of report
Mar 23, 2015
Accepted (ET)
Mar 23, 2015 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 23, 2015 | S | 38,725 | $68.96 | D | 8,475 | D | |
| Common StockF3 | Mar 23, 2015 | S | 6,575 | $69.79 | D | 1,900 | D | |
| Common StockF4 | Mar 23, 2015 | S | 1,900 | $70.57 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan entered into on August 14, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.44 to $69.43 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.45 to $70.35 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.45 to $70.74 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.